Issue Information
Total Page:16
File Type:pdf, Size:1020Kb
Volume 6 Number 2 February 2016 ISSN 2211-5463 febsopenbio.org FFEB4_v6_i2_IssueEB4_v6_i2_Issue info.inddinfo.indd 1 116-02-20166-02-2016 16:51:2516:51:25 EDITORIAL BOARD EDITORIAL OFFICE Senior Editors Laszlo Nagy Mary Purton, Executive Editor, FEBS Open Bio SBP Medical Discovery Institute, USA 98 Regent Street, Cambridge CB2 1DPUK Julio Celis and University of Debrecen, Hungary Institute of Cancer Biology, [email protected] Copenhagen, Denmark Zhen-Ming Pei Duke University, Durham, North Carolina, PRODUCTION OFFICE Stuart Ferguson USA University of Oxford, UK Marion Laws Jan S. Potempa Seamus Martin John Wiley & Sons Ltd, 9600 Garsington Road, Jagiellonian University Kraków, Poland Trinity College, Dublin, Ireland Oxford OX4 2DQ, UK Thomas Preiss [email protected] Felix Wieland Australian National University, Canberra, Ruprecht-Karls-Universität Heidelberg, Volume 6 Number 2 February 2016 Australia ISSN 1742-464X Germany Kristine Kleivi Sahlberg Associate Editors Oslo University Hospital, Norway Alberto Alape Giron Cristiano Simone Universidad de Costa Rica, San José, Università degli Studi di Bari Costa Rica Aldo Moro, Bari, Italy febsopenbio.org Edurne Berra Ramírez FEB4_v6_i2_oc.indd 1 16-02-2016 16:42:00 Sandro Sonnino CIC Biogune, DERIO, Spain Università degli Studi di Milano, Cover Illustration Antonio Castrillo Viguera Segrate, Italy In vivo fluorescence correlation spectroscopy analyses of FMBP-1, a silkworm transcription factor. From M. Tsutsumi et al. (pp. 106ă125). Instituto Investigaciones Biomedicas Michael Sussman Alberto Sols, Madrid, Spain University of Wisconsin at Madison, USA Pierre Cosson Tibor Vellai Université de Genève, Centre Medical Eötvös Lorand University, Budapest, Online ISSN: 2211-5463 Universitaire, Geneve 4-CH, Hungary This journal is Open Access; all articles will be immediately and Switzerland permanently free for everyone to read and download. Permitted reuse is B.G. Vértessy Miguel De la Rosa defined by a Creative Commons user license: Institute of Enzymology, Budapest, Creative Commons Attribution (CC BY) http://creativecommons. Consejo Superior de Investigaciones Hungary org/licenses/by/4.0/ lets others distribute and copy the article, to remix, Científicas (CSIC), Sevilla, Spain transform and build upon the material, to text or data mine the article, Rick Wansink Takashi Gojobori even for commercial purposes, as long as they credit the author(s), Radboud University Medical Center, National Institute of Genetics, indicate if changes were made, and do not represent the author as Nijmegen, Netherlands Mishima, Shizuoka, endorsing the adaptation of the article. Japan A. Wlodawer Disclaimer The Publisher and Editors cannot be held responsible Frederick, MD, USA Jörg Kobarg for errors or any consequences arising from the use of information LNBio-Laboratório Nacional de Koji Yamanaka contained in this journal; the views and opinions expressed do not Biociências, Campinas-SP, Brazil Nagoya University, Japan necessarily reflect those of the Publisher and Editors, neither does the publication of advertisements constitute any endorsements by the Dietmar J. Manstein Lei Yin Publisher and Editors of the products advertised. Hannover Medical School, University of Michigan Medical School, Wiley Open Access articles posted to repositories or websites are Germany USA without warranty from Wiley of any kind, either express or implied, including, but not limited to, warranties of merchantability, fitness for a particular purpose, or non-infringement. To the fullest extent permit- ted by law Wiley disclaims all liability for any loss or damage arising out of, or in connection with, the use of or inability to use the content. FFEB4_v6_i2_IssueEB4_v6_i2_Issue info.inddinfo.indd 2 116-02-20166-02-2016 16:51:2516:51:25 INFORMATION FOR AUTHORS AIMS AND SCOPE FEBS Open Bio is an online-only Open Access journal for the rapid publication of research articles in molecular and cellular life sciences in both health and disease. The journalÊs peer review process focuses on the technical soundness of papers, leaving the assessment of their impact and importance to the scientific community. FEBS Open Bio is owned by the Federation of European Biochemical Societies (FEBS, http://www.febs.org), a charity whose objectives are to promote research and education in the molecular life sciences. Any income from the journal will be used to support scientists through fellowships, courses, travel grants, and other FEBS initiatives. FEBS Open Bio publishes experimental findings, critical analysis, methodological and technical innovations, and hypotheses. Novel or innovative work is encouraged, but papers describing sound science of a confirmatory nature in developing fields or extending knowledge of an important topic from one organism to another will also be considered. Articles originally submitted to other FEBS Press publications (FEBS Letters, The FEBS Journal and Molecular Oncology) can be transferred for consideration by FEBS Open Bio with their original reviewer reports, without the need to resubmit or reformat the manuscript. FEBS Open Bio offers: ● Easy online manuscript submission and tracking system ● Fast and helpful peer review ă median time to first decision 25 days in 2015 ● Transfer service for articles from other FEBS Press journals, conserving peer reviews ● Fast publication ■ Accepted articles published online within 7 days (subject to receipt of a signed license agreement) ■ Author-corrected final version available within 20 days (subject to receipt of Article Publication Charge) ● All articles are deposited in PubMed Central and indexed in PubMed SUBMISSION PROCEDURE Papers should be submitted using the FEBS Open Bio online submission system, https://mc.manuscriptcentral.com/febsopen. You will be guided stepwise through the creation and uploading of your files. The system automatically converts source files to a single PDF file of the article, which is used in the peer-review process. You are welcome to submit your manuscript as a single file to be used in the peer-review process. Only when your paper reaches final revision stage will you be requested to deliver the individual files in the correct format for publication of your article. Complete information on the journalÊs policies and guidelines for the preparation on manuscripts for submission to the journal can be obtained from http://www.febsopenbio.org or by contacting the editorial office [email protected] OPEN ACCESS PUBLICATION FEE FEBS Open Bio is an Open Access journal with no subscribers. A fee is payable by the author or research funder to cover the costs associated with publication. This ensures each article will be immediately and permanently free for anyone to access. The Open Access publication fee for this journal is $1350, excluding taxes. Authors will be asked to pay the article publication charge on acceptance of their article. Your institute or funder may have an agreement with Wiley to pay all or some of the article publication charge on your behalf. You can check at http://olabout. wiley.com/WileyCDA/Section/id-420429.html. Waivers and discounts are available to authors from countries eligible for the Research4Life programs. You can check the lists of countries at http://www.wileyopenaccess.com/details/content/13707a1ddf6/Waivers-and-Discounts-on-Article-Publication- Charges.html. EVALUATION OF MANUSCRIPTS All submitted manuscripts undergo a technical check in the editorial office to ensure they comply with the journalÊs Guide to Authors. Manuscripts are then assigned to member of the Editorial Board with the appropriate expertise. The handling editor decides whether the article is of sufficient quality for consideration, and if so, invites two expert reviewers. Reviewers are asked to judge whether each paper reports original, primary work, on the soundness of the experimental data and if this data supports the conclusions drawn. The handling editor makes the final decision of whether to accept, reject or invite revision of a manuscript. Our median time to first decision in 2015 is 25 days. For inquiries relating to the submission or reviewing process, please contact: Editorial Office, FEBS Open Bio, 98 Regent Street, Cambridge CB2 1DP, UK. Tel: +44 1223 367011 Email: [email protected] FFEB4_v6_i2_IssueEB4_v6_i2_Issue info.inddinfo.indd 3 116-02-20166-02-2016 16:51:2516:51:25.